News & Events

Scientists from the Laboratory of Neurodegenerative Diseases (CNRS/CEA/University of Paris-Saclay) and the Neurocentre Magendie (Inserm/University of Bordeaux) have just highlighted the decisive role played by a metabolic pathway in memory impairment in Alzheimer's disease. Their work, to be published on 3 March 2020 in Cell Metabolism, also shows that a particular amino acid intake, in the form of a dietary supplement, restores the spatial memory affected early in mice models of the disease. This is a promising avenue for alleviating Alzheimer's-related memory loss.

Impairment of Glycolysis-Derived L-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer’s Disease. Juliette Le Douce, Marianne Maugard, Julien Veran, Marco Matos, Pierrick Jégo, Pierre-Antoine Vigneron, Emilie Faivre, Xavier Toussay,Michel Vandenberghe, Yaël Balbastre, Juliette Piquet, Elvire Guiot, Nguyet Thuy Tran, Myriam Taverna, Stéphane Marinesco, Ayumi Koyanagi, Shigeki Furuya, Mylène Gaudin-Guerif, Sébastien Goutal, Aurélie Ghettas, Alain Pruvost, Alexis-Pierre Bemelmans, Marie-Claude Gaillard, Karine Cambon, Lev Stimmer, Véronique Sazdovitch, Charles Duyckaerts, Graham Knott, Anne-Sophie Hérard, Thierry Delzescaux, Philippe Hantraye, Emmanuel Brouillet, Bruno Cauli, Stéphane H.R. Oliet, Aude Panatier et Gilles Bonvento. Cell Metabolism, le 3 mars 2020. DOI : 10.1016/j.cmet.2020.02.004

26/02/2020 10h00
Gianluca LAVANCO from Marsicano's lab will give a presentation entitled “What is the role of the mitochondrial CB1 receptor in the cannabinoid-induced modulation of learning and memory and synaptic plasticity?”

26/02/2020 10h30
Jennifer STANIC from Montcouquiol-Sans's lab will give a presentation entitled 'The PSD-95 spatial nano-architecture is altered by Scribble-dependent signaling'

14/02/2020 11h30
Chantal Mathis

Lieu: Neurocentre Magendie Seminar room

from DR2 CNRS, LNCA, Strasbourg's lab will give a presentation entitled 'Early memory deficits appearing during preclinical stages in mouse models of Alzheimer disease'

Invited by Nora Abrous (Neurocentre Magendie)


Over the last decade, the main finding about Alzheimer’s disease (AD) is that initial signs have been detected 15 to 20 years before diagnosis (e.g., see Bateman et al, 2012 and Jack et al, 2009). Since then, a great deal of efforts concentrated on the identification of early events and biomarkers that might help us to understand AD pathogenesis. The nature and severity of recognition deficits evolve as AD pathology spreads through medial temporal lobe networks and connected brain structures playing a key role in recognition memories. Therefore, object recognition paradigms have been useful to determine early memory deficits in animal models of AD. The pertinence of behavioral data provided by these paradigms will be analyzed in regard to the neuropathological phenotype of genetically modified rodent models of AD. Our aim is to outline clear advantages and possible limitations in their translational value. We propose that future progress depends on understanding neural networks supporting each form of recognition memory in parallel with the improvement of animal models of AD.

Lieu: Agora du Domaine du Haut-Carré (Talence)

MetaboDay aims at promoting interactions between researchers of the Bordeaux area interested in the various aspects of metabolism. This scientific event is open to researchers, post-docs and PhD students from all fields.

Registration is free but mandatory.

Pour plus de détails:

29/01/2020 10h00
Imane HUREL from Marsicano's lab will give a presentation entitled 'Choosing between exercise and food in a closed economy setting: role of CB1 receptors'

29/01/2020 10h30
Vincent SIMON from Cota's lab will give a presentation entitled ' "Uniting FISH and IHC techniques: a tale of wonder and despair"'